• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张型心肌病的自然病史和转归的性别和年龄差异。

Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.

机构信息

Cardiovascular Research Centre and Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.

National Heart & Lung Institute, Imperial College, London, UK.

出版信息

Eur J Heart Fail. 2018 Oct;20(10):1392-1400. doi: 10.1002/ejhf.1216. Epub 2018 Jun 3.

DOI:10.1002/ejhf.1216
PMID:29862606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6392171/
Abstract

AIM

To evaluate the relationship between sex, age and outcome in dilated cardiomyopathy (DCM).

METHODS AND RESULTS

We used proportional hazard modelling to examine the association between sex, age and all-cause mortality in consecutive patients with DCM. Overall, 881 patients (290 women, median age 52 years) were followed for a median of 4.9 years. Women were more likely to present with heart failure (64.0% vs. 54.5%; P = 0.007) and had more severe symptoms (P < 0.0001) compared to men. Women had smaller left ventricular end-diastolic volume (125 mL/m vs. 135 mL/m ; P < 0.001), higher left ventricular ejection fraction (40.2% vs. 37.9%; P = 0.019) and were less likely to have mid-wall late gadolinium enhancement (23.0% vs. 38.9%; P < 0.0001). During follow-up, 149 (16.9%) patients died, including 41 (4.7%) who died suddenly. After adjustment, all-cause mortality [hazard ratio (HR) 0.61, 95% confidence interval (CI) 0.41-0.92; P = 0.018] was lower in women, with similar trends for cardiovascular (HR 0.60, 95% CI 0.35-1.05; P = 0.07), non-sudden (HR 0.63, 95% CI 0.39-1.02; P = 0.06) and sudden death (HR 0.70, 95% CI 0.30-1.63; P = 0.41). All-cause mortality (per 10 years: HR 1.36, 95% CI 1.20-1.55; P < 0.0001) and non-sudden death (per 10 years: HR 1.51, 95% CI 1.26-1.82; P < 0.00001) increased with age. Cumulative incidence curves confirmed favourable outcomes, particularly in women and those <60 years. Increased all-cause mortality in patients >60 years of age was driven by non-sudden death.

CONCLUSION

Women with DCM have better survival compared to men, which may partly be due to less severe left ventricular dysfunction and a smaller scar burden. There is increased mortality driven by non-sudden death in patients >60 years of age that is less marked in women. Outcomes with contemporary treatment were favourable, with a low incidence of sudden death.

摘要

目的

评估性别、年龄与扩张型心肌病(DCM)结局的关系。

方法和结果

我们使用比例风险模型来研究 DCM 连续患者中性别、年龄与全因死亡率之间的相关性。共有 881 例患者(290 例女性,中位年龄 52 岁)接受了中位时间为 4.9 年的随访。与男性相比,女性更易出现心力衰竭(64.0% vs. 54.5%;P=0.007),且症状更严重(P<0.0001)。女性的左心室舒张末期容积更小(125ml/m vs. 135ml/m;P<0.001),左心室射血分数更高(40.2% vs. 37.9%;P=0.019),且中壁晚期钆增强的发生率更低(23.0% vs. 38.9%;P<0.0001)。随访期间,149 例(16.9%)患者死亡,包括 41 例(4.7%)猝死。调整后,女性的全因死亡率[风险比(HR)0.61,95%置信区间(CI)0.41-0.92;P=0.018]较低,且心血管死亡率[HR 0.60,95%CI 0.35-1.05;P=0.07]、非猝死性死亡率[HR 0.63,95%CI 0.39-1.02;P=0.06]和猝死性死亡率[HR 0.70,95%CI 0.30-1.63;P=0.41]也有相似的降低趋势。全因死亡率(每 10 年:HR 1.36,95%CI 1.20-1.55;P<0.0001)和非猝死性死亡率(每 10 年:HR 1.51,95%CI 1.26-1.82;P<0.00001)随年龄增加而增加。累积发病率曲线证实了有利的结果,尤其是在女性和<60 岁的患者中。60 岁以上患者全因死亡率的增加是由非猝死性死亡驱动的。

结论

与男性相比,女性 DCM 患者的生存率更好,这可能部分归因于左心室功能障碍程度较轻和瘢痕负荷较小。60 岁以上患者的全因死亡率增加是由非猝死性死亡驱动的,而女性的这种趋势不那么明显。在接受当代治疗的患者中,结局良好,猝死发生率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/6607470/b9205928e3c9/EJHF-20-1392-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/6607470/efd6577134a3/EJHF-20-1392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/6607470/cdf2150d2464/EJHF-20-1392-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/6607470/b9205928e3c9/EJHF-20-1392-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/6607470/efd6577134a3/EJHF-20-1392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/6607470/cdf2150d2464/EJHF-20-1392-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/090d/6607470/b9205928e3c9/EJHF-20-1392-g002.jpg

相似文献

1
Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.扩张型心肌病的自然病史和转归的性别和年龄差异。
Eur J Heart Fail. 2018 Oct;20(10):1392-1400. doi: 10.1002/ejhf.1216. Epub 2018 Jun 3.
2
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.扩张型心肌病伴轻中度左心室收缩功能障碍患者中壁晚期钆增强与心源性猝死的关联
Circulation. 2017 May 30;135(22):2106-2115. doi: 10.1161/CIRCULATIONAHA.116.026910. Epub 2017 Mar 28.
3
Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.心脏磁共振检查心肌纤维化的存在和程度对非缺血性扩张型心肌病心律失常转归和心源性猝死的影响。
Heart Rhythm. 2014 May;11(5):856-63. doi: 10.1016/j.hrthm.2014.01.014. Epub 2014 Jan 15.
4
Precision prediction of heart failure events in patients with dilated cardiomyopathy and mildly reduced ejection fraction using multi-parametric cardiovascular magnetic resonance.使用多参数心血管磁共振对扩张型心肌病和射血分数轻度降低患者的心力衰竭事件进行精准预测。
Eur J Heart Fail. 2024 Dec;26(12):2553-2562. doi: 10.1002/ejhf.3425. Epub 2024 Aug 15.
5
Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes.非扩张性左心室心肌病与扩张性心肌病:临床背景与结局。
ESC Heart Fail. 2024 Jun;11(3):1463-1471. doi: 10.1002/ehf2.14711. Epub 2024 Feb 6.
6
Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes.左心室射血分数≤35%的扩张型心肌病的预后与风险分层:心脏磁共振成像对改善预后的见解
Circ Cardiovasc Imaging. 2025 Mar;18(3):e017246. doi: 10.1161/CIRCIMAGING.124.017246. Epub 2025 Mar 18.
7
Ventricular Arrhythmias and Sudden Death in Nonischemic Dilated Cardiomyopathy: Matter of Sex or Scar?非缺血性扩张型心肌病中的室性心律失常和心原性猝死:与性别相关还是与瘢痕相关?
J Card Fail. 2022 Aug;28(8):1278-1286. doi: 10.1016/j.cardfail.2022.01.019. Epub 2022 Feb 15.
8
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.非缺血性扩张型心肌病患者纤维化与死亡率和心源性猝死的关系。
JAMA. 2013 Mar 6;309(9):896-908. doi: 10.1001/jama.2013.1363.
9
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy.扩张型心肌病的长期预后存在性别差异。
Can J Cardiol. 2020 Jan;36(1):37-44. doi: 10.1016/j.cjca.2019.05.031. Epub 2019 May 30.
10
Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy.左心室舒张功能障碍会使扩张型心肌病所致心力衰竭患者的预后恶化。
ESC Heart Fail. 2025 Apr;12(2):1183-1193. doi: 10.1002/ehf2.15119. Epub 2024 Nov 4.

引用本文的文献

1
Tailored therapeutics for cardiomyopathies.针对心肌病的个性化疗法。
Nat Rev Cardiol. 2025 Jun 27. doi: 10.1038/s41569-025-01183-6.
2
The Impact of Cardio-Renal-Metabolic Profile in Dilated Cardiomyopathy.心脏-肾脏-代谢特征在扩张型心肌病中的影响
Curr Cardiol Rep. 2025 May 23;27(1):89. doi: 10.1007/s11886-025-02241-8.
3
Incidence and determinants of left ventricular ejection fraction (LVEF) recovery in heart failure with reduced ejection fraction (HFrEF) of non-ischemic aetiology; a hospital-based prospective longitudinal registry study.

本文引用的文献

1
Sex Dimorphism in the Myocardial Response to Aortic Stenosis.主动脉狭窄心肌反应的性别二态性。
JACC Cardiovasc Imaging. 2018 Jul;11(7):962-973. doi: 10.1016/j.jcmg.2017.08.025. Epub 2017 Nov 15.
2
Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者一级预防植入型心律转复除颤器的年龄和结局。
Circulation. 2017 Nov 7;136(19):1772-1780. doi: 10.1161/CIRCULATIONAHA.117.028829. Epub 2017 Sep 6.
3
Declining Risk of Sudden Death in Heart Failure.
非缺血性病因的射血分数降低的心力衰竭(HFrEF)患者左心室射血分数(LVEF)恢复的发生率及决定因素;一项基于医院的前瞻性纵向登记研究。
Indian Heart J. 2025 May-Jun;77(3):188-192. doi: 10.1016/j.ihj.2025.03.016. Epub 2025 Apr 3.
4
Nexilin mutations, a cause of chronic heart failure: A state-of-the-art review starting from a clinical case.Nexilin突变——慢性心力衰竭的一个病因:从一个临床病例开始的最新综述
World J Cardiol. 2025 Mar 26;17(3):100290. doi: 10.4330/wjc.v17.i3.100290.
5
Mendelian Randomization Study on the Associations Between Genetically Predicted Cardiovascular Disease Subtypes and the Risk of Developing Cardiomyopathies.关于基因预测的心血管疾病亚型与心肌病发生风险之间关联的孟德尔随机化研究。
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251328011. doi: 10.1177/10760296251328011. Epub 2025 Mar 28.
6
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal.急性心力衰竭与非缺血性心肌病:全面综述与批判性评价
Diagnostics (Basel). 2025 Feb 23;15(5):540. doi: 10.3390/diagnostics15050540.
7
Epigenetics of cardiomyopathies: the next frontier.心肌病的表观遗传学:新的前沿领域。
Heart Fail Rev. 2025 Jan;30(1):257-270. doi: 10.1007/s10741-024-10460-4. Epub 2024 Nov 26.
8
The value of D-dimer in the prognosis of dilated cardiomyopathy: a retrospective cohort study.D-二聚体对扩张型心肌病预后的价值:一项回顾性队列研究。
Sci Rep. 2024 Nov 5;14(1):26806. doi: 10.1038/s41598-024-76716-z.
9
Association between coronary microvascular dysfunction and exercise capacity in dilated cardiomyopathy.扩张型心肌病中冠状动脉微血管功能障碍与运动能力之间的关联
J Cardiovasc Magn Reson. 2024;26(2):101108. doi: 10.1016/j.jocmr.2024.101108. Epub 2024 Oct 18.
10
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine.扩张型心肌病的病理生理学:从机制到精准医学
Nat Rev Cardiol. 2025 Mar;22(3):183-198. doi: 10.1038/s41569-024-01074-2. Epub 2024 Oct 11.
心力衰竭患者猝死风险降低。
N Engl J Med. 2017 Jul 6;377(1):41-51. doi: 10.1056/NEJMoa1609758.
4
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.扩张型心肌病伴轻中度左心室收缩功能障碍患者中壁晚期钆增强与心源性猝死的关联
Circulation. 2017 May 30;135(22):2106-2115. doi: 10.1161/CIRCULATIONAHA.116.026910. Epub 2017 Mar 28.
5
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome.性激素影响致心律失常性右室心肌病/发育异常的预后:从基于干细胞衍生心肌细胞的模型到疾病预后的临床生物标志物
Eur Heart J. 2017 May 14;38(19):1498-1508. doi: 10.1093/eurheartj/ehx011.
6
Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.植入式心脏复律除颤器用于左心室功能障碍伴或不伴缺血性心脏病患者的一级预防死亡:11 项试验中 8567 例患者的荟萃分析。
Eur Heart J. 2017 Jun 7;38(22):1738-1746. doi: 10.1093/eurheartj/ehx028.
7
Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.用于非缺血性心肌病的植入式心脏复律除颤器:一项更新的荟萃分析。
Circulation. 2017 Jan 10;135(2):201-203. doi: 10.1161/CIRCULATIONAHA.116.026056. Epub 2016 Dec 19.
8
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者的除颤器植入
N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27.
9
The Diagnosis and Evaluation of Dilated Cardiomyopathy.扩张型心肌病的诊断与评估。
J Am Coll Cardiol. 2016 Jun 28;67(25):2996-3010. doi: 10.1016/j.jacc.2016.03.590.
10
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.